Allergan plc

AbbVie is in talks to sell its women's drug business, which makes the Lo Loestrin Fe birth control pill, in an auction, according to Reuters.

AbbVie is rallying now that the company has closed its mega-deal with Allergan. The stock is looking to possibly test 2020 highs.

Jim Cramer discusses the stock market today including the collapse of the oil market, the cannabis stock sector and AbbVie potentially trending up.

Jim says we can beat this, but he's not calling the bottom. While we wait, he's hunting for income-generating securities.

Stocks trade higher even though new cases of the coronavirus have risen. The Nasdaq sets an all-time intraday high.

Allergan said it won't host an conference call with analysts to discuss Q4 earnings, but sees $63 billion AbbVie deal closing in the first quarter of this year.

Stock futures are mixed as the number of new cases of the coronavirus rises in China; factories and businesses in China struggle to get running following an extended break; Tesla's factory in Shanghai resumes production.

Jim Cramer says earnings are what should matter next week, but he urged caution. Even strong earnings and economic reports could be hit by coronavirus news.

Don't be too glib about recession talk, says Jim Cramer. Instead, be informed.

AbbVie is rallying Monday as the company divests assets to get approval for its Allergan deal and as the company tries to help treat the coronavirus.

Stocks plunge as investors weigh both the human and economic costs of the accelerating spread of the deadly coronavirus.

Allergan agrees to sell two of its drugs – Brazikumab and Zenpep – to Nestle and AstraZeneca to satisfy regulators ahead of its merger with AbbVie.

Stock futures sink as investors weigh the human and economic costs of the accelerating spread of the deadly coronavirus; Apple, Facebook, Microsoft and Amazon report earnings this week; basketball legend Kobe Bryant dies in a helicopter crash.

The AbbVie bond deal could become one of the largest as the North Chicago biopharma pushes ahead with plans to acquire Allergan, Bloomberg reported.

The Dow Jones Industrial Average and the Nasdaq both hit record closes Tuesday, one day after the three major U.S. benchmark indexes posted record closing highs.

Allergan posted stronger-than-expected third quarter earnings Tuesday, and boosted its full-year revenue guidance, as the Botox maker said its $63 billion takeover by biopharmaceutical group AbbVie would close early next year.

U.S. stock futures rise a day after the three major U.S. benchmark indexes posted record closing highs on positive trade developments between the U.S. and China and strong corporate earnings; Uber posts $1.2 billion loss but sees profitability in 2021; Shake Shacks sinks on a weak same-store sales forecast.

The drugmaker nudges its guidance for the final three months of the year slightly higher, even as sales of its top-selling arthritis drug Humira come in lower than expected.

Trump administration taps former GlaxoSmithKline exec as head of vaccine task force, and how I'm playing Walmart and Datadog.

The purchase of the Botox maker should inject fresh growth and income to this health care name.

I have always liked the aggressive management.

Jim talks earnings from Disney, CVS Health, and more!

What's really driving the market, what's making the Nasdaq roar? Tech and science, that's what.

Don't just follow the herd, time your exits and entrances well -- even if it is a big player like Warren Buffett that is leading the charge.

AbbVie, Clorox, Colgate-Palmolive and Honeywell report Friday.

One sector noticeably outperforming Monday is health care.

We still believe the prudent action to take is to lighten up into strength on several positions where we see some earnings risk.

When it's beaten you will wish you own stocks, especially the stocks that are right now lethal to your portfolio.

We will sell some shares of AbbVie and Honeywell.

After a company reports we all know what's wrong, it's immunized. And that's when you can buy.

Heading into the the second quarter, we list price changes on our holdings.

Here are six companies that should come through in the tough times ahead.

We view Bristol-Myers's current level as attractive.

Amid a flood of corporate warnings over the coronavirus, all the major stock market indexes finished last month down 6.4% to 10.1%.

But don't throw up your arms yet -- here are names that could be golden opportunities.

Newly confirmed cases of the Covid-19 virus spiked from Hubei Province in China, where the city of Wuhan is located. The number of related deaths increased as well.

China-based Alibaba reports quarterly performance Thursday morning. While one might think that an e-commerce type operation could do well in a quarantined environment, it's not quite that easy.

Mark Zuckerberg's AI team unveiled big plans for AI in an email chain

These 10 compact and midsized sport utility vehicles earned CR’s highest marks, and they sell for wallet-friendly prices.

Here’s what could be next in the AI boom.